CDAK
Codiak BioSciences, Inc. Common Stock
CDAK
CDAK
Delisted
CDAK was delisted on the 4th of April, 2023.
51 hedge funds and large institutions have $145M invested in Codiak BioSciences, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
98% less call options, than puts
Call options by funds: $3K | Put options by funds: $131K
Holders
51
Holding in Top 10
2
Calls
$3K
Puts
$131K
Top Buyers
1 | +$1.37M | |
2 | +$395K | |
3 | +$301K | |
4 |
Geode Capital Management
Boston,
Massachusetts
|
+$274K |
5 |
HighTower Advisors
Chicago,
Illinois
|
+$237K |
Top Sellers
1 | -$2.33M | |
2 | -$2.01M | |
3 | -$783K | |
4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$455K |
5 |
![]()
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$361K |